Baker Bros. Advisors LP Burning Rock Biotech LTD Transaction History

Baker Bros. Advisors LP

  • $8.39 Billion
  • Q1 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$22.55 - $30.87 $635,210 - $869,577
-28,169 Reduced 11.87%
209,131 $4.83 Million
Q3 2020

Nov 16, 2020
SELL
$19.07 - $29.61 $242,189 - $376,047
-12,700 Reduced 5.08%
237,300 $5.95 Million
Q2 2020

Aug 14, 2020
BUY
$23.21 - $31.43 $5.8 Million - $7.86 Million
250,000 New
250,000 $6.75 Million

About Burning Rock Biotech Ltd

BNR Quotes by TradingView
  • Ticker BNR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 105,188,000
  • Market Cap $296M
  • Description
  • Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...
More about BNR
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email